Publications
5677 Results
- Journal / Conference
- Blood Advances Jan 24;7(2):196-204
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID36269846
- PMC
- PMC9841239
- Study Number(s)
- C10403
The impact of early PEG-asparaginase discontinuation in young adults with ALL: A post hoc analysis of the C10403 study
- Journal / Conference
- Blood Advances Apr 11;7(7):1279-1285
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID36322825
- PMC
- PMC10090098
- Study Number(s)
- S1318
Dasatinib/Prednisone Induction Followed by Blinatumomab/Dasatinib in Ph+ Acute Lymphoblastic Leukemia
- Journal / Conference
- Journal of Clinical Oncology Jan 10;41(2):186-197
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID36166727
- PMC
- PMC9839305
- Study Number(s)
- CTSU/EA6134
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
- Journal / Conference
- Journal of Clinical Oncology Apr 10;41(11):2020-2028
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36480773
- PMC
- PMC10082246
Population, Clinical, and Scientific Impact of National Cancer Institute’s National Clinical Trials Network Treatment Studies
- Journal / Conference
- JAMA Oncology Feb 1;9(2):251-260
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID36416836
- PMC
- PMC9685550
- Study Number(s)
- S1404
Effectiveness of adjuvant pembrolizumab improves quality-of-life outcomes compared to high dose interferon or ipilimumab in patients with resected melanoma; SWOG S1404, A Randomized Clinical Trial
- Journal / Conference
- Journal of Clinical Oncology Feb 10;41(5):1079-1091
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36367997
- PMC
- PMC9928634
- Study Number(s)
- CTSU/C80702
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy from Adjuvant Therapy in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)
- Journal / Conference
- Leukemia and Lymphoma Jan;64(1):250-252
- Year
- 2023
- Research Committee(s)
- Leukemia and Symptom Management and Survivorship
- PMID
- PMID36226777
- Study Number(s)
- S0432, S0702, S1612
Early Mortality Risk with Non-Intensive Acute Myeloid Leukemia (AML) Therapies: Analysis of 1,336 Patients from MRC/NCRI and SWOG
- Journal / Conference
- Journal of Clinical Oncology Jan 10;41(2):243-254
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35944235
- PMC
- PMC9839249
- Study Number(s)
- CTSU/C80702
Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
- Journal / Conference
- International Journal of Cancer Jan 15;152(2):123-136
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35904874
- PMC
- PMC9691576
- Study Number(s)
- CTSU/C80405
Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: data from CALGB 80405 (Alliance)
- Journal / Conference
- Annals of Surgical Oncology Mar;30(3):1354-1363
- Year
- 2023
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID36622529
- PMC
- PMC10695673
- Study Number(s)
- S0809